Polymerase chain reaction detection of rVSVΔG-ZEBOV-GP vaccine virus
| Study day | Specimen type | Vaccine, 1 × 105 pfu (n = 10) | Vaccine, 5 × 105 pfu (n = 10) | Vaccine, 3 × 106 pfu (n = 10) | All vaccine subjects (n = 30) |
|---|---|---|---|---|---|
| No. of positive samples/no. of samples tested (%) | |||||
| 1 | Blood | 0 | 0 | 2/10 (20) | 2/30 (6.7) |
| Saliva | 0 | 0 | 0 | 0 | |
| Urine | 0 | 0 | 0 | 0 | |
| 3 | Blood | 5/10 (50) | 5/10 (50) | 8/10 (80) | 18/30 (60) |
| Saliva | 0 | 0 | 0 | 0 | |
| Urine | 0 | 0 | 0 | 0 | |
| 7 | Blood | 0 | 0 | 0 | 0 |
| Saliva | 0 | 0 | 0 | 0 | |
| Urine | 0 | 0 | 0 | 0 | |
| 14 | Blood | 0 | 0 | 0 | 0 |
| Saliva | 0 | 0 | 0 | 0 | |
| Urine | 0 | 0 | 0 | 0 | |
Note: Study day is relative to vaccination day, which is study day 0. pfu = plaque-forming units.